Brief: Panbela Provides Business Update And Reports Q4 And FY 2022 Financial Results
16/03/2023 22:50
March 16 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA PROVIDES BUSINESS UPDATE AND REPORTS Q4 AND FY
2022
FINANCIAL RESULTS
* PANBELA THERAPEUTICS INC - QTRLY BASIC AND DILUTED NET
LOSS PER
SHARE $5.68
* PANBELA THERAPEUTICS INC - TOTAL CASH WAS $1.3 MILLION AS
OF
DECEMBER 31, 2022
Source text for Eikon: ID:nGNX26TNxz
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants